Clinical inertia: viewpoints of general practitioners and diabetologists

Diabetes Metab. 2012 Mar;38 Suppl 3:S53-8. doi: 10.1016/S1262-3636(12)71535-5.

Abstract

Large clinical studies have enabled best practice guidelines to be issued. Intended to serve practitioners in their daily practice, the guidelines are also excellent tools for assessing physician performance. It was therefore demonstrated that despite the observation of insufficient glycaemic control, physicians did not systematically increase drug treatments. As a result, they have been accused of clinical inertia! In this journal, we first try to reveal what is behind this concept and to differentiate true inertia from pseudo inertia. Secondly, we consider how general practitioners and diabetologists, through their respective positions, can develop a synergy that is able to fight against inertia but that can especially, improve the glycaemic control of our patients.

MeSH terms

  • Attitude of Health Personnel*
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Administration Schedule
  • Female
  • France
  • General Practitioners / statistics & numerical data*
  • Guideline Adherence
  • Humans
  • Internal Medicine
  • Male
  • Medication Adherence / statistics & numerical data*
  • Physician-Patient Relations
  • Practice Guidelines as Topic